STOCK TITAN

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Sight Sciences (Nasdaq: SGHT), an eyecare technology company, will release its Q2 2025 financial results on August 7, 2025, after market close. The company will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results.

Investors can access the live webcast and replay of the event through the company's website at www.sightsciences.com in the Investors section under News & Events. The webcast replay will be available for at least 90 days following the event.

Sight Sciences (Nasdaq: SGHT), un'azienda tecnologica nel settore dell'oftalmologia, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 il 7 agosto 2025, dopo la chiusura del mercato. L'azienda terrà una conference call alle 13:30 PT / 16:30 ET per discutere i risultati.

Gli investitori potranno seguire la diretta streaming e la registrazione dell'evento sul sito web della società, www.sightsciences.com, nella sezione Investitori sotto Notizie & Eventi. La registrazione sarà disponibile per almeno 90 giorni dopo l'evento.

Sight Sciences (Nasdaq: SGHT), una empresa tecnológica en el cuidado ocular, publicará sus resultados financieros del segundo trimestre de 2025 el 7 de agosto de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica a las 1:30 PM PT / 4:30 PM ET para analizar los resultados.

Los inversores podrán acceder a la transmisión en vivo y a la repetición del evento a través del sitio web de la empresa en www.sightsciences.com, en la sección de Inversores bajo Noticias y Eventos. La repetición estará disponible por al menos 90 días después del evento.

Sight Sciences (나스닥: SGHT)는 안과 기술 회사로서, 2025년 2분기 재무 실적2025년 8월 7일 장 마감 후에 발표할 예정입니다. 회사는 오후 1시 30분 PT / 오후 4시 30분 ET에 실적 발표 관련 컨퍼런스 콜을 진행합니다.

투자자들은 회사 웹사이트 www.sightsciences.com의 투자자 섹션 내 뉴스 및 이벤트에서 생중계 및 녹화 영상을 시청할 수 있습니다. 녹화 영상은 행사 후 최소 90일간 제공됩니다.

Sight Sciences (Nasdaq : SGHT), une entreprise technologique spécialisée dans les soins oculaires, publiera ses résultats financiers du deuxième trimestre 2025 le 7 août 2025 après la clôture du marché. La société organisera une conférence téléphonique à 13h30 PT / 16h30 ET pour discuter des résultats.

Les investisseurs pourront accéder à la diffusion en direct et au replay de l'événement via le site internet de la société, www.sightsciences.com, dans la section Investisseurs sous Actualités & Événements. Le replay sera disponible pendant au moins 90 jours après l'événement.

Sight Sciences (Nasdaq: SGHT), ein Unternehmen für Augengesundheitstechnologie, wird seine Finanzergebnisse für das zweite Quartal 2025 am 7. August 2025 nach Börsenschluss veröffentlichen. Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz zur Besprechung der Ergebnisse abhalten.

Investoren können den Live-Webcast und die Aufzeichnung der Veranstaltung über die Website des Unternehmens unter www.sightsciences.com im Bereich Investoren unter Nachrichten & Veranstaltungen abrufen. Die Aufzeichnung wird mindestens 90 Tage nach der Veranstaltung verfügbar sein.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced it will report financial results for the second quarter ended June 30, 2025, after the market close on Thursday, August 7, 2025. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.sightsciences.com, on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event.

About Sight Sciences

Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System and OMNI® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.

Sight Sciences, the Sight Sciences logo, TearCare, and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories.

© 2025 Sight Sciences. All rights reserved.

Media contact:
pr@sightsciences.com

Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
investor.relations@sightsciences.com


FAQ

When will Sight Sciences (SGHT) report Q2 2025 earnings?

Sight Sciences will report Q2 2025 earnings on August 7, 2025, after the market close.

What time is the Sight Sciences (SGHT) Q2 2025 earnings call?

The earnings conference call will begin at 1:30 PM Pacific Time / 4:30 PM Eastern Time on August 7, 2025.

How can I listen to Sight Sciences (SGHT) Q2 2025 earnings call?

Investors can access the live webcast at www.sightsciences.com in the Investors page under News & Events section.

How long will the Sight Sciences (SGHT) Q2 2025 earnings webcast be available?

The webcast replay will be available for at least 90 days after the event.
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

SGHT Latest News

SGHT Latest SEC Filings

SGHT Stock Data

178.89M
40.75M
20.6%
54.74%
3.04%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK